Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines.
about
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunizationProbing the Substrate Specificity of Golgi α-Mannosidase II by Use of Synthetic Oligosaccharides and a Catalytic Nucleophile MutantIdentification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus.Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in miceNovel strategies and therapeutics for the treatment of prostate carcinoma.NGcGM3 ganglioside: a privileged target for cancer vaccinesTranslating tumor antigens into cancer vaccinesSynthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine CandidatesDetection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer.Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines.Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouseMeta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.Carbohydrate vaccines as immunotherapy for cancer.Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines.Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccinesInduction of leukocyte infiltration at metastatic site mediates the protective effect of NGcGM3-based vaccine.A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinicCombining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy.Immunotherapy for cancer: synthetic carbohydrate-based vaccines.Recent development in carbohydrate-based cancer vaccines.Eliciting carbohydrate-specific immune response against sialosides: success and challenges.Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies.Carbohydrate-based cancer vaccines: target cancer with sugar bullets.Glycopolymers and glyco-nanoparticles in biomolecular recognition processes and vaccine development.Cloning and characterization of a viral α2-3-sialyltransferase (vST3Gal-I) for the synthesis of sialyl Lewisx.Accessibility of N-acyl-D-mannosamines to N-acetyl-D-neuraminic acid aldolase.Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine.Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity.Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells.Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans.Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.Melanoma vaccines: prospects for the treatment of melanoma.Immunogenicity of membrane-bound gangliosides in viable whole-cell vaccines.Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale.Development of vaccine strategies for the treatment of B-cell malignancies.Evaluation of Virus-Like Particle-Based Tumor-Associated Carbohydrate Immunogen in a Mouse Tumor Model.Cardiovascular exercise intervention improves the primary antibody response to keyhole limpet hemocyanin (KLH) in previously sedentary older adults.
P2860
Q24655648-97E3DD40-F9A9-4BE8-9666-6A60DA235CC5Q27650852-A73830DF-5808-43BD-A787-9ADD1F1C5B3CQ30406634-B15C0BB3-20A2-4A50-B774-9292AC713ED2Q33312280-EA27C8AC-231F-4354-BB30-041AEC14A3A5Q34043331-37E039D5-F41A-4C16-8A35-C5C88235F05CQ34247856-7626AA5C-0C76-4DA4-A88A-F398F04D3DC7Q34484042-924D60FE-E114-43EA-AA3C-F56CCDAC049EQ35212122-A00F5F33-83B5-4F4C-B6FB-D97F3718BC67Q35224101-A7DFCEAC-28A7-440F-BE0E-62E54415080DQ35234194-4B47DD08-4782-4FAE-A28B-35E7A4E0AE89Q35623390-43CC4BCE-773B-43D2-8866-A7A1E4933FA1Q35685656-3E6C572F-93F7-411A-B94D-5B9DC6E2FE5AQ36009558-D7C98CC5-10AB-4788-A6D6-18E2419788A4Q36201691-4FD8F5B2-3F5A-4FBD-BA33-FFDD7EAD7191Q36802325-1C259268-1E6B-4E79-8B6E-7B1DF5BF401AQ36868822-457E80B3-4B75-4589-AB46-50B396842658Q36978403-915DD3ED-834D-431F-A257-EEA3D312CC53Q37303845-0ED8BD90-06A0-4675-96D1-25A92BCDA749Q37418500-E87B35A5-66C5-407F-AC32-11ED7A87EB28Q37453814-4A958283-8AB5-4E32-A6BA-50A678A441C8Q37455940-992DC325-AAC8-42A5-B44D-5CC57570EC00Q37869901-D0812993-12D5-4CE6-93BA-F9E8F3EF0578Q37974938-61E4D668-3602-413C-BE16-8FA418685D96Q37993590-C477A30D-E651-41B2-9A82-61B1A6109A3AQ38016342-48DE56CB-03CF-446D-84EE-571D4DC39BC1Q38050110-80270B46-2958-4835-8280-1D337789EB31Q38339801-FF80ADBC-8233-4DDA-B6B9-C620AEBC8040Q38538715-EFBEAEFC-8266-457E-A168-D9FD17ACACF1Q39750020-46B51950-364A-46CA-B3F8-8F81DBA88EEAQ40343581-07BE89D8-E878-4A06-828D-3D29CF54D1E1Q40467105-BC0B4D71-6260-41C1-8332-AEBF1A33B079Q40572917-6C806C60-E8EC-45DB-B24A-097364F11401Q40879087-470316CA-7CFF-43C4-A831-AF45665B5915Q40896263-659D7545-B5D1-485E-99C6-8392479C2694Q40900776-8BAE5DD3-A103-49A5-B505-2663CF8B444EQ41605409-1A04146A-8D94-42C0-8990-811D792E46F2Q41629044-70AD5549-5343-4428-94BE-BC0F31C84CB8Q41669410-D2BF342A-9358-4D52-ADDF-7CCF35B40084Q41932626-A1481AA7-F8EF-4081-AE47-AA516032C332Q42217223-F1353C1E-F2D0-431E-9786-1DA1A15E936F
P2860
Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Approaches to augmenting the i ...... ioside-KLH conjugate vaccines.
@en
type
label
Approaches to augmenting the i ...... ioside-KLH conjugate vaccines.
@en
prefLabel
Approaches to augmenting the i ...... ioside-KLH conjugate vaccines.
@en
P2860
P1476
Approaches to augmenting the i ...... ioside-KLH conjugate vaccines.
@en
P2093
P O Livingston
P2860
P304
P356
10.1111/J.1600-065X.1995.TB00080.X
P577
1995-06-01T00:00:00Z